Elevated plasma fibrinogen associated with reduced pulmonary function

M. Dahl, A. Tybjaerg-Hansen, J. Vestbo, P. Lange, B. G. Nordestgaard (Herlev, Copenhagen, Hvidovre, Denmark)

Source: Annual Congress 2001 - Markers of obstructive lung disease
Session: Markers of obstructive lung disease
Session type: Oral Presentation
Number: 3406
Disease area: Airway diseases

Congress or journal article abstract

Abstract

We tested whether increased concentrations of the acute phase reactant fibrinogen correlate with reduced pulmonary function, stratified by smoking status. We measured plasma fibrinogen and FEV1 in 8872 adults from the Danish general population. Smokers with plasma fibrinogen in the upper and middle tertile (>3.3 and 2.7-3.3 g/L) had FEV1 of 88% and 93% predicted compared with 94% in smokers with fibrinogen in the lower tertile (<2.7 g/L) (Mann-Whitney: P<0.001 and P=0.02). The equivalent values in nonsmokers were 97% and 101% compared with 101% (P<0.001 and P=0.90). Analysis of covariance allowing for potential confounders demonstrated that smokers in the upper and middle tertile had 166 and 59 ml less in FEV1 than smokers in the lower tertile (F statistic: P<0.001). The equivalent values for nonsmokers were 136 and 32 ml (P<0.001). We demonstrate for the first time that increased levels of plasma fibrinogen are associated with reduced lung function, and that this association is most pronounced in smokers.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Dahl, A. Tybjaerg-Hansen, J. Vestbo, P. Lange, B. G. Nordestgaard (Herlev, Copenhagen, Hvidovre, Denmark). Elevated plasma fibrinogen associated with reduced pulmonary function. Eur Respir J 2001; 16: Suppl. 31, 3406

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019

Elevated D-dimer and low ferritin may help predict pulmonary emboli in mild-moderate COVID-19
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021


Severe a1-antitrypsin deficiency associated with reduced blood pressure and lower plasma triglycerides in the general population
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021


Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010

Inflammation-sensitive plasma proteins are associated with increased incidence of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 629s
Year: 2007

Reduced heart rate variability is associated with increased level of serum ICAM-1 in patients with sarcoidosis
Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside
Year: 2010

Plasma levels of soluble RAGE are lower in COPD
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009


Elevated C-reactive protein is associated with reduced lung function and exercise capacity in normal subjects. Are we born inflammed?
Source: Eur Respir J 2006; 28: Suppl. 50, 331s
Year: 2006

L-arginine plasma levels correlate with severity of primary pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 560s
Year: 2004

Elevated pulmonary vascular resistance is associated with increased risk of death in IPF
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019

Decrease in circulating monocyte metalloproteinase-9 content with increasing severity of pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 5s
Year: 2002

Increased plasma fibrinogen could predict frequent exacerbations in asthma
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005

Elevated factor FVIII:C levels in patients with pulmonary hypertension: a marked of endothelial dysfunction?
Source: Eur Respir J 2003; 22: Suppl. 45, 584s
Year: 2003

Serum osteoprotegerin and fibulin-1 levels negatively correlate with DLCO in IPF
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019


Smoking cessation is associated with a reduction in vWF plasma levels
Source: Eur Respir J 2004; 24: Suppl. 48, 98s
Year: 2004

Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012

Serum leptin – is it associated with levels of airway responsiveness?
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018

Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013